Natixis Schrodinger, Inc. Transaction History

Natixis

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$26.1 - $49.92 $620,527 - $1.19 Million	23,775 New	23,775 $1.19 Million
Q4 2022 Feb 13, 2023	SELL	$16.24 - $26.38 $52,390 - $85,101	-3,226 Reduced 5.72%	53,220 $994,000
Q3 2022 Nov 14, 2022	SELL	$23.95 - $34.71 $99,129 - $143,664	-4,139 Reduced 6.83%	56,446 $1.45 Million
Q2 2022 Aug 12, 2022	BUY	$21.39 - $35.9 $765,184 - $1.28 Million	35,773 Added 144.18%	60,585 $1.61 Million
Q1 2022 May 13, 2022	SELL	$24.84 - $36.12 $48,562 - $70,614	-1,955 Reduced 7.3%	24,812 $847,000
Q4 2021 Feb 14, 2022	SELL	$33.38 - $59.25 $39,722 - $70,507	-1,190 Reduced 4.26%	26,767 $932,000
Q3 2021 Nov 12, 2021	BUY	$53.75 - $76.55 $1.5 Million - $2.14 Million	27,957 New	27,957 $1.53 Million
Q2 2021 Aug 13, 2021	SELL	$59.02 - $78.8 $1.51 Million - $2.02 Million	-25,635 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$64.61 - $113.09 $1.66 Million - $2.9 Million	25,635 New	25,635 $1.96 Million

236

61M

726K

329K

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.33B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.